UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2023 » Volume 31, issue 2 (115) » THE PROBLEM OF PROFILE AND DURATION OF COGNITIVE IMPAIRMENTS ASSOCIATED WITH COVID-19 (literature review)

THE PROBLEM OF PROFILE AND DURATION OF COGNITIVE IMPAIRMENTS ASSOCIATED WITH COVID-19 (literature review)

Authors

Type of Article

  • Scientific Article

In the Section

  • LITERATURE REVIEW

Key words

Index UDK:
  • 616.89-008.46:616.89-008.47:616.9-079.

Abstract

The article provides a review of results of researches, systematic reviews and meta-analyses dealt with peculiarities of cognitive impairments (profile, prevalence, duration) and methodological approaches to their detection in persons after coronavirus disease 2019 (COVID-19). The presented data proved that a systematic cognitive assessment (long-term and with appropriate instruments) of patients who had COVID-19 has to be an important element of the everyday clinical practice, as an early detection and interventions could improve solving problems associated with cognitive deficits after COVID-19 in the long term.

Pages

  • 98-104

Year / Issue

UVP_Т_31_2_115_2023_14_нікішковаDownload PDF

References

  1. Management of corona virus disease-19 (COVID-19): the Zhejiang experience / K. Xu, H. Cai, Y. Shen [et аl.] // Zhejiang da xue bao Yi  xue ban [J. Zhejiang. Univ. Med. Sci.]. 2020. Vol.  49(2). P.  147—157. Chinese. DOI: https://doi.org/10.3785/j.issn.1008-9292.2020.02.02.
  2. Al‐Aly Z. High‐dimensional characterization of post‐acute sequelae of COVID‐19 / Z. Al‐Aly, Y. Xie, B. Bowe // Nature. 2021. Vol. 594(7862). P. 259—264. DOI: https://doi.org/10.1038/s41586-021-03553-9.
  3. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 / K. Duan, E. Premi, A. Pilotto [et al.] // Neurobiol. Stress. 2021. Vol. 14: 100326. DOI: https://doi.org/10.1016/j.ynstr.2021.100326.
  4. Post-infection cognitive impairments in a  cohort of  elderly patients with COVID-19 / Y.-H. Liu, Y.-R. Wang, Q.-H. Wang [et  ]  // Molecular Neurodegeneration. 2021. Vol.  16(1): 48. DOI: https://doi.org/10.1186/s13024-021-00469-w.
  5. COVID-19 associated cognitive impairment: A systematic review / J.W.L. Tavares-Júnior, A.C.C. de Souza, J.W.P. Borges [et  ]  // Cortex. 2022. Vol.  152. P.  77—97. DOI: https://doi.org/10.1016/j.cortex.2022.04.006.
  6. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a  cross-sectional evaluation  / S. J. Halpin, C. McIvor, G. Whyatt [et аl.] // J. Med. Virol. 2021. Vol. 93(2). P. 1013—1022. DOI: https://doi.org/10.1002/jmv.26368.
  7. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life / S. Poletti, M. Palladini, M. G. Mazza [et аl.] // Eur. Arch. Psychiatry Clin. Neurosci. 2022. Vol. 272(5). P. 773—782. DOI: https://doi.org/10.1007/s00406-021-01346-9.
  8. Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment / Almeria M., Cejudo J. C., Sotoca J. [et аl.] // Brain Behav. Immun. Health. 2020. Vol. 9: 100163. DOI: https://doi.org/10.1016/j.bbih.2020.100163.
  9. Neurologic features in severe SARS-CoV-2 іnfection / J. Helms, S. Kremer, H. Merdji [et аl.] // N. Engl. J. Med. 2020. Vol. 382(23). P. 2268—2270. DOI: https://doi.org/10.1056/NEJMc2008597.
  10. Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase / B. Coleman, E. Casiraghi, H. Blau [et аl.] // World Psychiatry. 2022. Vol. 21(2. P. 319—320. DOI: https://doi.org/10.1002/wps.20992.
  11. Ritchie K. The emergence of cognitive COVID / K. Ritchie, D. Chan // World Psychiatry. 2021. Vol.  20(1). P.  52—53. DOI: https://doi.org/10.1002/wps.20837.
  12. Two-year physical, mental and cognitive outcomes among intensive care unit survivors treated for COVID-19 / [H. Heesakkers, J.G. van der Hoeven, M. van den Boogaard, M. Zegers]  //Intensive Care Med. 2023. Vol.  P.  1—3. DOI: https://doi.org/10.1007/s00134-023-07038-3.
  13. One‐year cognitive follow‐up of COVID‐19 hospitalized patients // R. Ferrucci, M. Dini, C. Rosci [et аl.] // Eur. J. Neurol. 2022. Vol. 29(7). P. 2006—2014. DOI: https://doi.org/10.1111/ene.15324.
  14. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID‐19 / Hosp J.  , Dressing A., Blazhenets G. [et  аl.]  // Brain. 2021. Vol.  144(4). P. 1263—1276. DOI: https://doi.org/10.1093/brain/awab009.
  15. Allen T. Y. Long-term neuropsychiatric complications and 18F-FDG-PET hypometabolism in the brain from prolonged infection of COVID-19  / T. Y.  Allen, N.    Absar  // Alzheimer Dis. Assoc. Disord. 2022. Vol. 36(2). P. 173—175. DOI: https://doi.org/10.1097/WAD.0000000000000485.
  16. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex / J. Hugon, E.   Msika, M.  Queneau [et  аl.]  // J. Neurol. 2022. Vol.  269(1). P.  44—46. DOI: https://doi.org/10.1007/s00415-021-10655-x.
  17. Post-COVID-19 human memory impairment: A PRISMAbased systematic review of evidence from brain imaging studies / D. Shan, S. Li, R. Xu [et аl.] // Front. Aging Neurosci. 2022. Vol. 14: 1077384. DOI: https://doi.org/10.3389/fnagi.2022.1077384.
  18. A review of pathophysiology and neuropsychiatric manifestations of COVID-19 / [M. Jasti, K. Nalleballe, V. Dandu, S. Onteddu] // J. Neurol. 2021. Vol. 268(6). P. 2007—2012. DOI: https://doi.org/10.1007/s00415-020-09950-w.
  19. Changes in cognitive functioning after COVID‐19: A systematic review and meta‐analysis / L. Crivelli, K. Palmer, I. Calandri [et аl.] // Alzheimers Dement. 2022. Vol. 18(5). P. 1047—1066. DOI: https://doi.org/10.1002/alz.12644.
  20. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta‐analysis with comparison to the COVID‐19 pandemic  / J. P. Rogers, E. Chesney, D. Oliver [et аl.] // Lancet Psychiatry. 2020. Vol. 7 (7). P. 611—627. DOI: https://doi.org/10.1016/S2215-0366(20)30203-0.
  21. Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review / K. Honarmand, R.   Lalli, F. Priestap [et аl.] // Am. J. Respir. Crit. Care Med. 2020. Vol. 202(2). P. 193—201. DOI: https://doi.org/10.1164/rccm.201904-0816CI.
  22. MONITOR-IC study, a mixed methods prospective multicentre controlled cohort study assessing 5-year outcomes of ICU survivors and related healthcare costs: a study protocol / W. Geense, M. Zegers, H. Vermeulen [et аl.] // BMJ Open. 2017. Vol. 7(11). e018006. DOI: https://doi.org/10.1136/bmjopen-2017-018006.
  23. Is the frontal lobe the primary target of SARS-CoV-2? / S. Toniolo, F. Di Lorenzo, M. Scarioni [et аl.] // J Alzheimers Dis. 2021. Vol. 81(1). P. 75—81. DOI: https://doi.org/10.3233/JAD-210008.
  24. 18F-FDG brain PET hypometabolism in patients with long COVID // Guedj E., Campion J.Y., Dudouet P. [et  аl.]  // Eur.    Nucl. Med. Mol. Imag. 2021. Vol.  48(9). P.  2823—2833. DOI: https://doi.org/10.1007/s00259-021-05215-4.
  25. Cerebral micro-structural changes in COVID-19 patients — an MRI-based 3-month follow-up study: a brief title: cerebral changes in COVID-19 / Y. Lu, X. Li, D. Geng [et аl.] // EClinicalMedicine. 2020. Vol. 25: 100484. DOI: https://doi.org/10.1016/j.eclinm.2020.100484.
  26. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients / G. Blazhenets, N. Schroeter, T. Bormann [et аl.] /  / J.  Med. 2021. Vol.  62(7). P.  910—915. DOI: https://doi.org/10.2967/jnumed.121.262128.
  27. The cerebral network of COVID-19-related encephalopathy: a  longitudinal voxel-based 18F-FDG-PET study  / Kas  , M. Soret, N. Pyatigoskaya [et  аl.]  // Eur. J. Nucl. Med. Mol. Imaging. 2021. Vol.  48(8). P.  2543—2557. DOI: https://doi.org/10.1007/s00259-020-05178-y.
  28. COVID‐19 cognitive deficits after respiratory assistance in the subacute phase: A COVID rehabilitation unit experience / F. Alemanno, E. Houdayer, A. Parma [et аl.] // PLoS ONE. 2021. Vol. 16(2). e0246590. DOI: https://doi.org/10.1371/journal.pone.0246590.
  29. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19 / A.  Jaywant, W.  Vanderlind, G.  S. Alexopoulos [et  аl.]  // Neuropsychopharmacol. 2021. Vol.  46(13). P.  2235—2240. DOI: https://doi.org/10.1038/s41386-021-00978-8.
  30. Persistent COVID‐19‐associated neurocognitive symptoms in non‐hospitalized patients / J. Hellmuth, T. A. Barnett, B. M. Asken, [et аl.] // J. Neurovirol. 2021. Vol. 27(1). P. 191—195. DOI: https://doi.org/10.1007/s13365-021-00954-4.
  31. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation / F. Negrini, I. Ferrario, D. Mazziotti [et аl.] // Arch. Phys. Med. Rehabil. 2021. Vol. 102(1). P. 155—158. DOI: https://doi.org/10.1016/j.apmr.2020.09.376.
  32. Prolonged neuropsychological deficits, central nervous system involvement, and brain stem affection after COVID‐19‐A case series / S. Groiss, C. Balloff, S. Elben [et  аl.]  // Front. Neurol. 2020. Vol.  11: 574004. DOI: https://doi.org/10.3389/fneur.2020.574004.
  33. Pattern of cognitive deficits in severe COVID‐19 / V.  Beaud, S. Crottaz‐Herbette, V. Dunet, [et  аl.]  // J. Neurol. Neurosurg. Psychiatry. 2021. Vol. 92(5). P. 567—568. DOI: https://doi.org/10.1136/jnnp-2020-325173.
  34. Early attention impairment in a patient with COVID-19 / [J. Tolentino, A.L.T. Gjorup, G. J. Schmidt, S.  L. Schmidt]  // Psychiatry. Clin. Neurosci. 2021. Vol.  75(2). P.  66—67. DOI: https://doi.org/10.1111/pcn.13178.
  35. Neurocognitive deficits in severe COVID‐19 infection: Case series and proposed model / D. M. Whiteside, V. Oleynick, E. Holker [et аl.] // Clin. Neuropsychol. 2021. Vol. 35(4). P. 799— 818. DOI: https://doi.org/10.1080/13854046.2021.1874056.
  36. Yesilkaya U. H. COVID‐19‐related cognitive dysfunction may be associated with transient disruption in the DLPFC glutamatergic pathway / U. H. Yesilkaya, M. Sen, Y. H. Balcioglu // J. Neurosci. 2021. Vol. 87. P.  153—155. DOI: https://doi.org/10.1016/j.jocn.2021.03.007.
  37. Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors / [A. Henneghan, K. A. Lewis, E.  Gill, S. R. Kesler] // Front. Psychol. 2022. Vol. 13: 770459. DOI: https://doi.org/10.3389/fpsyg.2022.770459.
  38. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers” / E.L. Graham, J. R. Clark, Z. S. Orban [et аl.] // Ann. Clin. Transl. Neurol. 2021. Vol. 8. P. 1073—1085. DOI: https://doi.org/10.1002/acn3.51350.
  39. The landscape of cognitive function in  recovered COVID-19 patients / H. Zhou, S. Lu, J. Chen [et  аl.]  // J.  Res. 2020. Vol.  129. P.  98—102. DOI: https://doi.org/10.1016/j.jpsychires.2020.06.022.
  40. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors / R. Méndez, V. Balanzá-Martínez, S. C. Luperdi [et аl.] // J. Intern. Med. 2021. Vol. 290(3). P. 621— 631. DOI: https://doi.org/10.1111/joim.13262.
  41. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up / M. G. Mazza, M. Palladini, R.  De  Lorenzo [et  аl.]  // Brain Behav. Immun. 2021. Vol.  P. 138—147. DOI: https://doi.org/10.1016/j.bbi.2021.02.021.
  42. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 / E. Garrigues, P. Janvier, Y. Kherabi [et аl.] // J. Infect. 2020. Vol. 81(6). e4—e6. DOI: https://doi.org/10.1016/j.jinf.2020.08.029.
  43. Cognitive, behavioral, and psychological manifestations of COVID-19 in post-acute rehabilitation setting: preliminary data of  an  observational study / [S. Bonizzato, A. Ghiggia, F. Ferraro, E. Galante] // Neurol. Sci. 2022. Vol. 43(1). P. 51—58. DOI: https://doi.org/10.1007/s10072-021-05653-w.
  44. Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19 / T. D. Vannorsdall, E. Brigham, A. Fawzy [et аl.] // J. Acad. Consult. Liaison Psychiatry. 2022. Vol. 63(2). P. 133—143. DOI: https://doi.org/10.1016/j.jaclp.2021.10.006.
  45. Assessment of cognitive function in patients after COVID‐19 infection / J. H. Becker, J. J. Lin, M. Doernberg [et аl.] // JAMA Netw. Open. 2021. Vol.  4(10). e2130645. DOI: https://doi.org/10.1001/jamanetworkopen.2021.30645.
  46. Self-reported memory problems 8 months after COVID-19 infection / A. Søraas, R. Bø, K. T. Kalleberg [et аl.] // JAMA Netw. Open 2021. Vol. 4(7). e2118717—e2118717. DOI: https://doi.org/10.1001/jamanetworkopen.2021.18717.
  47. Post-COVID-19 memory complaints: prevalence and associated factors / M. Ahmed, S. Roy, M. Iktidar [et аl.]  // Neurología. 2022. DOI: https://doi.org/10.1016/j.nrl.2022.03.007.
  48. Anxiety and depression among general population in China at the peak of the COVID-19 epidemic / J. Li, Z. Yang, H. Qiu [et аl.] // World Psychiatry. 2020. Vol. 19(2). P. 249—250. DOI: https://doi.org/10.1002/wps.20758.
  49. Penninx B. Psychiatric symptoms and cognitive impairment in “Long COVID”: The relevance of immunopsychiatry / World Psychiatry. 2021. Vol. 20(3). P. 357—358. DOI: https://doi.org/10.1002/wps.20913.
  50. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables / K. W. Miskowiak, S. Johnsen, S. M. Sattler [et аl.] // Eur. 2021. Vol. 46. P.  39—48. DOI: https://doi.org/10.1016/j.euroneuro.2021.03.019.
  51. Givens J. L. Functional recovery after hip fracture: the combined effects of depressive symptoms, cognitive impairment, and delirium / J. L. Givens, T. B. Sanft, E. R. Marcantonio / J. Geriatr. Soc. 2008. Vol. 56(6). P. 1075—1079. DOI: https://doi.org/10.1111/j.1532-5415.2008.01711.x.
  52. Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature / A. Perrottelli, N. Sansone, G. Giordano [et  аl.]  // J. Pers. Med. 2022. Vol. 12(12). P. 2070. DOI: https://doi.org/10.3390/jpm12122070.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»